Related references
Note: Only part of the references are listed.Injection fears and COVID-19 vaccine hesitancy
Daniel Freeman et al.
PSYCHOLOGICAL MEDICINE (2023)
Lassa Virus Replicon Particle Vaccine Protects Strain 13/N Guinea Pigs Against Challenge With Geographically and Genetically Diverse Viral Strains
Jessica R. Spengler et al.
JOURNAL OF INFECTIOUS DISEASES (2022)
High-Throughput Platform for Detection of Neutralizing Antibodies Using Flavivirus Reporter Replicon Particles
Arlen-Celina Luecke et al.
VIRUSES-BASEL (2022)
Nipah Virus V Protein Binding Alters MDA5 Helicase Folding Dynamics
Nicole D. Wagner et al.
ACS INFECTIOUS DISEASES (2022)
Designing spatial and temporal control of vaccine responses
Gillie A. Roth et al.
NATURE REVIEWS MATERIALS (2022)
Establishment of a stable SARS-CoV-2 replicon system for application in high-throughput screening
Tomohisa Tanaka et al.
ANTIVIRAL RESEARCH (2022)
Development of Viral-Vectored Vaccines and Virus Replicon Particle-Based Neutralisation Assay against Mayaro Virus
Young Chan Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease
Stephanie L. Foster et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants
Brock Kingstad-Bakke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
The Role of Nucleoprotein in Immunity to Human Negative-Stranded RNA Viruses-Not Just Another Brick in the Viral Nucleocapsid
Maja Santak et al.
VIRUSES-BASEL (2022)
Incomplete bunyavirus particles can cooperatively support virus infection and spread
Erick Bermudez-Mendez et al.
PLOS BIOLOGY (2022)
Viral nucleoprotein antibodies activate TRIM21 and induce T cell immunity
Sarah L. Caddy et al.
EMBO JOURNAL (2021)
A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus
Thomas W. Geisbert et al.
NPJ VACCINES (2021)
Chimeric Fusion (F) and Attachment (G) Glycoprotein Antigen Delivery by mRNA as a Candidate Nipah Vaccine
Rebecca J. Loomis et al.
FRONTIERS IN IMMUNOLOGY (2021)
Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma
Harini Natarajan et al.
MBIO (2021)
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
Philippe Begin et al.
NATURE MEDICINE (2021)
An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
Ahmed O. Hassan et al.
CELL REPORTS (2021)
CryoEM structure of the Nipah virus nucleocapsid assembly
De-Sheng Ker et al.
PLOS PATHOGENS (2021)
Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination
Matthew J. Gorman et al.
CELL REPORTS MEDICINE (2021)
Viral replicon particles protect IFNAR-/- mice against lethal Crimean-Congo hemorrhagic fever virus challenge three days after vaccination
Jessica R. Spengler et al.
ANTIVIRAL RESEARCH (2021)
Evaluation of a Single-Dose Nucleoside-Modified Messenger RNA Vaccine Encoding Hendra Virus-Soluble Glycoprotein Against Lethal Nipah virus Challenge in Syrian Hamsters
Michael K. Lo et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Mumps: an Update on Outbreaks, Vaccine Efficacy, and Genomic Diversity
Eugene Lam et al.
CLINICAL MICROBIOLOGY REVIEWS (2020)
A Soluble Version of Nipah Virus Glycoprotein G Delivered by Vaccinia Virus MVA Activates Specific CD8 and CD4 T Cells in Mice
Georgia Kalodimou et al.
VIRUSES-BASEL (2020)
Viral replicons as valuable tools for drug discovery
Holger Hannemann
DRUG DISCOVERY TODAY (2020)
Identification of Common CD8+ T Cell Epitopes from Lassa Fever Survivors in Nigeria and Sierra Leone
Saori Sakabe et al.
JOURNAL OF VIROLOGY (2020)
Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen Development
Rebecca J. Loomis et al.
FRONTIERS IN IMMUNOLOGY (2020)
Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody
Mangaiarkarasi Asokan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
A hidden gene in astroviruses encodes a viroporin
Valeria Lulla et al.
NATURE COMMUNICATIONS (2020)
Vaccines to Emerging Viruses: Nipah and Hendra
Moushimi Amaya et al.
ANNUAL REVIEW OF VIROLOGY, VOL 7, 2020 (2020)
Potent Henipavirus Neutralization by Antibodies Recognizing Diverse Sites on Hendra and Nipah Virus Receptor Binding Protein
Jinhui Dong et al.
CELL (2020)
Interactions of the Nipah Virus P, V, and W Proteins across the STAT Family of Transcription Factors
Timothy R. Keiffer et al.
MSPHERE (2020)
Nipah virus dynamics in bats and implications for spillover to humans
Jonathan H. Epstein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
A Conserved Basic Patch and Central Kink in the Nipah Virus Phosphoprotein Multimerization Domain Are Essential for Polymerase Function
Jessica F. Bruhn et al.
STRUCTURE (2019)
Transmission of Nipah Virus-14 Years of Investigations in Bangladesh
Birgit Nikolay et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Mucosal vaccines and technology
A. Miquel-Clopes et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2019)
Protection From Lethal Lassa Disease Can Be Achieved Both Before and After Virus Exposure by Administration of Single-Cycle Replicating Lassa Virus Replicon Particles
Markus H. Kainulainen et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections
Ha V. Dang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)
The how's and what's of vaccine reactogenicity
Caroline Herve et al.
NPJ VACCINES (2019)
Heterologous protection against Crimean-Congo hemorrhagic fever in mice after a single dose of replicon particle vaccine
Jessica R. Spengler et al.
ANTIVIRAL RESEARCH (2019)
A structural basis for antibody-mediated neutralization of Nipah virus reveals a site of vulnerability at the fusion glycoprotein apex
Victoria A. Avanzato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Antagonism of STAT1 by Nipah virus P gene products modulates disease course but not lethal outcome in the ferret model
Benjamin A. Satterfield et al.
SCIENTIFIC REPORTS (2019)
Adaptive Immune Responses in Humans During Nipah Virus Acute and Convalescent Phases of Infection
Govindakarnavar Arunkumar et al.
CLINICAL INFECTIOUS DISEASES (2019)
Nipah Virus Outbreaks: Still Small but Extremely Lethal
Christina F. Spiropoulou
JOURNAL OF INFECTIOUS DISEASES (2019)
The Human CD4+ T Cell Response against Mumps Virus Targets a Broadly Recognized Nucleoprotein Epitope
Jelle de Wit et al.
JOURNAL OF VIROLOGY (2019)
Nasal route for vaccine and drug delivery: Features and current opportunities
Yadira Lobaina Mato
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Local and Systemic Immunity against Respiratory Syncytial Virus Induced by a Novel Intranasal Vaccine A Randomized, Double-Blind, Placebo-controlled Clinical Trial
Stephanie Ascough et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Single-dose replicon particle vaccine provides complete protection against Crimean-Congo hemorrhagic fever virus in mice
Florine E. M. Scholte et al.
EMERGING MICROBES & INFECTIONS (2019)
Pathogenicity of Nipah henipavirus Bangladesh in a swine host
S. B. Kasloff et al.
SCIENTIFIC REPORTS (2019)
Use of a Scalable Replicon-Particle Vaccine to Protect Against Lethal Lassa Virus Infection in the Guinea Pig Model
Markus H. Kainulainen et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Paramyxovirus V Proteins Interact with the RIG-I/TRIM25 Regulatory Complex and Inhibit RIG-I Signaling
Maria T. Sanchez-Aparicio et al.
JOURNAL OF VIROLOGY (2018)
A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus
Bronwyn M. Gunn et al.
CELL HOST & MICROBE (2018)
Analysis of CD8+ T cell response during the 2013-2016 Ebola epidemic in West Africa
Saori Sakabe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
High-throughput neutralization assay for multiple flaviviruses based on single-round infectious particles using dengue virus type 1 reporter replicon
Mami Matsuda et al.
SCIENTIFIC REPORTS (2018)
Utility of Japanese encephalitis virus subgenomic replicon-based single-round infectious particles as antigens in neutralization tests for Zika virus and three other flaviviruses
Atsushi Yamanaka et al.
JOURNAL OF VIROLOGICAL METHODS (2017)
Gene end-like sequences within the 3′ non-coding region of the Nipah virus genome attenuate viral gene transcription
Akihiro Sugai et al.
VIROLOGY (2017)
Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection
David J. DiLillo et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response
Brad S. Pickering et al.
VACCINE (2016)
Status of vaccine research and development of vaccines for Nipah virus
Benjamin A. Satterfield et al.
VACCINE (2016)
The Matrix Protein of Nipah Virus Targets the E3-Ubiquitin Ligase TRIM6 to Inhibit the IKKε Kinase-Mediated Type-I IFN Antiviral Response
Preeti Bharaj et al.
PLOS PATHOGENS (2016)
Nipah Virus Transmission from Bats to Humans Associated with Drinking Traditional Liquor Made from Date Palm Sap, Bangladesh, 2011-2014
M. Saiful Islam et al.
EMERGING INFECTIOUS DISEASES (2016)
Human Ebola virus infection results in substantial immune activation
Anita K. McElroy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Vaccine hesitancy: Definition, scope and determinants
Noni E. MacDonald
VACCINE (2015)
Animal models of disease shed light on Nipah virus pathogenesis and transmission
Emmie de Wit et al.
JOURNAL OF PATHOLOGY (2015)
Virus-Like Particles Activate Type I Interferon Pathways to Facilitate Post-Exposure Protection against Ebola Virus Infection
Natarajan Ayithan et al.
PLOS ONE (2015)
Intranasal Adenovirus-Vectored Vaccine for Induction of Long-Lasting Humoral Immunity-Mediated Broad Protection against Influenza in Mice
Eun Hye Kim et al.
JOURNAL OF VIROLOGY (2014)
Nipah Virion Entry Kinetics, Composition, and Conformational Changes Determined by Enzymatic Virus-Like Particles and New Flow Virometry Tools
Matthew Landowski et al.
JOURNAL OF VIROLOGY (2014)
Evaluation of single-round infectious, chimeric dengue type 1 virus as an antigen for dengue functional antibody assays
Atsushi Yamanaka et al.
VACCINE (2014)
Recent developments in experimental animal models of Henipavirus infection
Barry Rockx
PATHOGENS AND DISEASE (2014)
Characterization of a third generation lentiviral vector pseudotyped with Nipah virus envelope proteins for endothelial cell transduction
S. R. Witting et al.
GENE THERAPY (2013)
Nudeoprotein of influenza A virus is a major target of immunodominant CD8+ T-cell responses
Emma Grant et al.
IMMUNOLOGY AND CELL BIOLOGY (2013)
Virus replicon particle based Chikungunya virus neutralization assay using Gaussia luciferase as readout
Sabine Glaesker et al.
VIROLOGY JOURNAL (2013)
Crystal Structure of the Hendra Virus Attachment G Glycoprotein Bound to a Potent Cross-Reactive Neutralizing Human Monoclonal Antibody
Kai Xu et al.
PLOS PATHOGENS (2013)
Henipavirus Infections: Lessons from Animal Models
Kevin P. Dhondt et al.
PATHOGENS (2013)
The immune response to Nipah virus infection
Joseph Prescott et al.
ARCHIVES OF VIROLOGY (2012)
Distinct and Overlapping Roles of Nipah Virus P Gene Products in Modulating the Human Endothelial Cell Antiviral Response
Michael K. Lo et al.
PLOS ONE (2012)
Pteropid Bats are Confirmed as the Reservoir Hosts of Henipaviruses: A Comprehensive Experimental Study of Virus Transmission
Kim Halpin et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
Successful respiratory immunization with dry powder live-attenuated measles virus vaccine in rhesus macaques
Wen-Hsuan Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Identification of Three Novel CTL Epitopes within Nucleocapsid Protein of Hantaan Virus
Meiliang Wang et al.
VIRAL IMMUNOLOGY (2011)
A neutralization test for specific detection of Nipah virus antibodies using pseudotyped vesicular stomatitis virus expressing green fluorescent protein
Yoshihiro Kaku et al.
JOURNAL OF VIROLOGICAL METHODS (2009)
Development of a neutralization assay for Nipah virus using pseudotype particles
Azaibi Tamin et al.
JOURNAL OF VIROLOGICAL METHODS (2009)
Simulating Henipavirus Multicycle Replication in a Screening Assay Leads to Identification of a Promising Candidate for Therapy
Matteo Porotto et al.
JOURNAL OF VIROLOGY (2009)
Animal models for the study of emerging zoonotic viruses: Nipah and Hendra
Branka Horvat
VETERINARY JOURNAL (2009)
Acute Hendra virus infection: Analysis of the pathogenesis and passive antibody protection in the hamster model
Vanessa Guillaume et al.
VIROLOGY (2009)
Immune responses to mumps vaccine in adults who were vaccinated in childhood
Rima Hanna-Wakim et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Cellular immunity to mumps virus in young adults 21 years after measles-mumps-rubella vaccination
Sari Jokinen et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Two key residues in ephrinB3 are critical for its use as an alternative receptor for Nipah virus
Oscar A. Negrete et al.
PLOS PATHOGENS (2006)
Nipah virus-assodiated encephalitis outbreak, Siliguri, India
MS Chadha et al.
EMERGING INFECTIOUS DISEASES (2006)
Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus
MI Bonaparte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus
OA Negrete et al.
NATURE (2005)
Invasion of the central nervous system in a porcine host by Nipah virus
H Weingartl et al.
JOURNAL OF VIROLOGY (2005)
Nipah virus conforms to the rule of six in a minigenome replication assay
K Halpin et al.
JOURNAL OF GENERAL VIROLOGY (2004)
Nipath virus encephalitis reemergence, Bangladesh
VP Hsu et al.
EMERGING INFECTIOUS DISEASES (2004)
The nucleoprotein is required for efficient coronavirus genome replication
F Almazán et al.
JOURNAL OF VIROLOGY (2004)
Relapsed and late-onset Nipah encephalitis
CT Tan et al.
ANNALS OF NEUROLOGY (2002)
Experimental Nipah virus infection in pigs and cats
DJ Middleton et al.
JOURNAL OF COMPARATIVE PATHOLOGY (2002)
Case-control study of risk factors for human infection with a new zoonotic paramyxovirus, Nipah virus, during a 1998-1999 outbreak of severe encephalitis in Malaysia
UD Parashar et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
